CKMed
ActiveSummary
CKMed has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €221k and a net result of €112k. Its solvency ranks better than 63% of 16618 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency100▲+34
Growth52
Track record82
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €21k at 30 days only on tighter terms
Liquidity ample (current ratio 5.77 against 1.81 in 2024; short-term debt: 14.5% and cash: 65.5% of total assets), and 24.6% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
75.4%
Return on assets
38.2%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 31-03-2026, 30 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
30 d early
2024
22 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€221k▲ 74.9%
2024 · €126k
Total assets
€293k▼ 4.6%
2024 · €307k
Net result
€112k▼ 19.3%
2024 · €138k
Working capital
€202k▲ 81.8%
2024 · €111k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20242025
Operating result€181k-€151k▼ 16.6%
Net result€138k-€112k▼ 19.3%
Equity€126k-€221k▲ 74.9%
Total assets€307k-€293k▼ 4.6%
Debt€181k-€72k▼ 60.2%
Working capital€111k-€202k▲ 81.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 17% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €293k
Fixed assets
€48k ▼ 18.7%
Current assets
€245k ▼ 1.2%
Equity and liabilities €293k
Equity
€221k ▲ 74.9%
Debt
€72k ▼ 60.2%
Debt's share of the balance-sheet total falls from 58.9% to 24.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€163k▼
2024 · €186k
Cash flow
€124k▼
2024 · €143k
Current ratio
5.77▲
2024 · 1.81
Debt to equity
0.33▼
2024 · 1.43
ROE
50.6%▼
2024 · 109.6%
ROA
38.2%▼
2024 · 45.1%
Interest coverage
40.94▼
2024 · 107.35
Debt ≤ 1 year
€42k▼
2024 · €137k
Debt > 1 year
€28k▼
2024 · €43k
Income taxes
€34k▼
2024 · €41k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €5k | €12k | ▲ 145% |
| Other operating charges640/8 | €50 | - | - |
| Gross operating margin9900 | €186k | €163k | ▼ 12.2% |
| Operating profit (loss)9901 | €181k | €151k | ▼ 16.6% |
| Financial income75/76B | €573 | €1k | ▲ 155% |
| Recurring financial income75 | €573 | €1k | ▲ 155% |
| Financial charges65/66B | €2k | €7k | ▲ 294% |
| Recurring financial charges65 | €2k | €4k | ▲ 130% |
| Non-recurring financial charges66B | - | €3k | - |
| Profit (loss) for the period before taxes9903 | €179k | €145k | ▼ 19.0% |
| Income taxes67/77 | €41k | €34k | ▼ 18.2% |
| Profit (loss) for the period9904 | €138k | €112k | ▼ 19.3% |
| Profit (loss) for the period to be appropriated9905 | €138k | €112k | ▼ 19.3% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €307k | €293k | ▼ 4.6% |
| Fixed assets21/28 | €59k | €48k | ▼ 18.7% |
| Tangible fixed assets22/27 | €59k | €48k | ▼ 18.7% |
| Plant, machinery and equipment23 | - | €578 | - |
| Furniture and vehicles24 | €59k | €47k | ▼ 19.7% |
| Current assets29/58 | €248k | €245k | ▼ 1.2% |
| Amounts receivable within one year40/41 | €84k | €27k | ▼ 68.1% |
| Trade receivables40 | €62k | €135 | ▼ 99.8% |
| Other amounts receivable41 | €22k | €27k | ▲ 22.7% |
| Cash at bank and in hand54/58 | €136k | €192k | ▲ 41.3% |
| Deferred charges and accrued income490/1 | €28k | €26k | ▼ 7.6% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €307k | €293k | ▼ 4.6% |
| Equity10/15 | €126k | €221k | ▲ 74.9% |
| Contributions10/11 | €2k | €2k | = |
| Reserves13 | €124k | €219k | ▲ 76.1% |
| Distributable reserves133 | €124k | €219k | ▲ 76.1% |
| Amounts payable17/49 | €181k | €72k | ▼ 60.2% |
| Amounts payable after more than one year17 | €43k | €28k | ▼ 34.0% |
| Financial debts170/4 | €43k | €28k | ▼ 34.0% |
| Amounts payable within one year42/48 | €137k | €42k | ▼ 68.9% |
| Current portion of amounts payable after more than one year42 | €14k | €15k | ▲ 4.0% |
| Trade debts44 | €65k | €1k | ▼ 98.2% |
| Suppliers440/4 | €65k | €1k | ▼ 98.2% |
| Taxes, remuneration and social security45 | €48k | €10k | ▼ 79.9% |
| Taxes450/3 | €45k | €7k | ▼ 84.4% |
| Remuneration and social security454/9 | €3k | €3k | ▲ 0.1% |
| Other amounts payable47/48 | €10k | €17k | ▲ 73.5% |
| Accrued charges and deferred income492/3 | €1k | €1k | = |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €138k | €112k | ▼ 19.3% |
| + Depreciation and write-downs630 | €5k | €12k | ▲ 145% |
| Operating cash flow (approximation) | €143k | €124k | ▼ 13.4% |
| Investment in fixed assets (approximation) | - | €-1k | - |
| Change in cash | - | €56k | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
More with these figures Sector benchmark What changed Value indication
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
Financial
Liquidity triplescurrent ratio 5.77
Current ratio from 1.81 to 5.77; short-term debt falls from €137k to €42k.
30-09
Financial
Equity above €200kEq €221k ▲74.9%
2 profitable years in a row build equity to €221k.
08-04
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Rixensart · 1 establishment unit since 2023
Ground area
1,983 m²
Building footprint
89 m²
Volume, LiDAR
728 m³
Parcel 25091E0223/00A000, Wallonia · tallest building 9.6 m, ±3 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
CKMed
since 20232.353.974.521
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25091E0223/00A000 | Wallonia | 1,983 m² | 1 · 88 m² | 9.6 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
984500941F45436D3E58
Similar companies · same sector, comparable size
DOKTER PIETER MATTELAER
BE 0480.068.440
Oostende · Eq €220,778
Alganes
BE 0543.349.656
Boortmeerbeek · Eq €220,701
Dr. Hannelore Bode
BE 0729.704.175
Roeselare · Eq €220,943
Docteur David LIBERT
BE 0555.868.396
Waterloo · Eq €221,161
Dr. Tom Vydt
BE 0823.382.520
Mechelen · Eq €221,184
Of 16,630 companies in sector 86220 we hold annual accounts for 7,979. 6,663 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded28-12-2023
Fiscal year end30-09
Activities, NACEBEL 2025
86220Specialist medical practice
Scores and ratios are computed by Checked and are not a credit decision.